Erythromycin 250 mg Tablets
Zydus is recalling Erythromycin 250 mg tablets due to the presence of N-Nitroso-Desmethyl-Erythromycin above acceptable intake limits.
Contact your healthcare provider or pharmacist to discuss alternative treatment options and return the affected medication to the place of purchase.
Why it was recalled
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
How to identify it
Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; a) 30 count bottles (NDC 70710-1047-3); b) 100 count bottles (NDC 70710-1047-1).
Where it was sold
Distributed in US.
Official source
Other recent recalls from Zydus Pharmaceuticals (USA) Inc
Editorial summary by Recall Canary · last updated 2026-06-05 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification